Author

J. Paggetti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

E. Moussay· 2 shared A. Cosma· 1 shared A. Floerchinger· 1 shared A. Lesur· 1 shared A. Oudin· 1 shared A. Rosenwald· 1 shared C. Jaeger· 1 shared C. Pulido· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. Moussay

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle

M. Benzarti, A. Oudin, E. Viry, E. Gargiulo, M. Schmoetten, L. Neises, C. Pulido, N. I. Lorenz, M. W. Ronellenfitsch, D. Sumpton, M. Warmoes, C. Jaeger, A. Lesur, J. Paggetti, E. Moussay, , J. Meiser

This study reveals that PKM2 inhibition redirects glycolytic and glutamine carbons into distinct metabolic pathways, supporting cancer cell metabolic flexibility under glycolytic limitation.

bioRxiv · Jan 23, 2023Cancer Biology

High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target

L. L. Cid, J. K. Leong, I. F. Botana, Y. Paul, M. Wierz, A. Floerchinger, S. Gonder, G. Pagano, M. Chazotte, K. Bestak, C. Schifflers, M. Iskar, T. Roider, F. Czernilofsky, P.-M. Bruch, , M. Seiffert

The paper defines CLL T cell subtypes and identifies Galectin-9 as a novel immunotherapy target through single-cell and multi-omics analyses.

bioRxiv · Dec 15, 2022 · PreprintCancer Biology